Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Net patient service revenue | $ 1,101,000 | $ 0 | $ 2,169,000 | $ 0 |
| Cost of patient services | 675,000 | 0 | 1,306,000 | 0 |
| Research and development | 2,116,000 | 987,000 | 3,425,000 | 1,791,000 |
| Selling, general and administrative | 4,745,000 | 2,743,000 | 8,557,000 | 5,686,000 |
| Depreciation and amortization | 66,000 | 0 | 134,000 | 0 |
| Settlement expense (income) | 4,000 | 0 | (3,000) | 100,000 |
| Total operating expenses | 7,606,000 | 3,730,000 | 13,419,000 | 7,577,000 |
| Loss from operations | (6,505,000) | (3,730,000) | (11,250,000) | (7,577,000) |
| Interest income | (6,000) | (2,000) | (11,000) | (6,000) |
| Interest expense | 240,000 | 0 | 470,000 | 0 |
| Change in fair value of convertible debt | 0 | 5,565,000 | 0 | 6,530,000 |
| Change in fair value of warrant liabilities | 9,784,000 | 6,414,000 | 6,246,000 | 3,518,000 |
| Loss on issuance of Registered Direct Offering | 0 | 0 | 0 | 729,000 |
| Loss on Consideration Shares and Warrants | 0 | 0 | 0 | 1,277,000 |
| Loss on convertible note conversions | 0 | 1,874,000 | 0 | 3,467,000 |
| Income from equity method investments | (3,000) | 0 | (5,000) | 0 |
| Total other expense, net | 10,015,000 | 13,851,000 | 6,700,000 | 15,515,000 |
| Net loss | $ (16,520,000) | $ (17,581,000) | $ (17,950,000) | $ (23,092,000) |
| Net loss per share: | ||||
| Basic and diluted (in dollars per share) | $ (0.44) | $ (0.98) | $ (0.51) | $ (1.34) |
| Weighted average Common Stock outstanding: | ||||
| Basic and diluted (in shares) | 37,649,382 | 17,934,196 | 34,933,437 | 17,176,339 |
| X | ||||||||||
- Definition Represents the fair value adjustment of convertible debt. No definition available.
|
| X | ||||||||||
- Definition The amount of gain/loss on consideration shares and warrants. No definition available.
|
| X | ||||||||||
- Definition The amount of gain (loss) on convertible debt redemption. No definition available.
|
| X | ||||||||||
- Definition The amount of gain/loss on the issuance of common stock. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|